Rate My Professor Russell Hogg

In addition to his academic and clinical roles, Russell Hogg engages with NSW Health advisory bodies and co-chairs the Gynaecological Oncology Network, as announced in March 2026, alongside Anne Mellon. He previously served as chair of the organising committee for the Australasian Society of Gynaecological Oncology (ASGO) annual scientific meeting held in Sydney in 2012. His research contributions center on gynaecological oncology, with a focus on ovarian cancer genomics, surgical techniques, and patient outcomes. Notable publications include the multinational LACE trial results, 'Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Quality of Life' (JAMA, 2017, cited by 535), 'BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition' (JCO Precision Oncology, 2018), 'Opportunistic bilateral salpingectomy during gynaecological surgery for benign pathology' (Australian and New Zealand Journal of Obstetrics and Gynaecology, 2015), 'Lower preoperative quality of life increases postoperative complications in gynaecological oncology patients' (Gynecologic Oncology, 2015), and 'Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for epithelial ovarian cancer' (European Journal of Cancer, 2012). Collectively, his 12 research works have accumulated 879 citations. Hogg has participated in clinical studies advancing ovarian cancer treatment protocols in New South Wales, including efforts to change surgical care patterns and achieve stage shifts in diagnoses.